ABSTRACT
Background Congenital cytomegalovirus (cCMV) is a leading cause of birth defects and the most common cause of non-genetic sensorineural hearing loss in children. There is a lack of decision modeling frameworks that can project cytomegalovirus (CMV)-related patient outcomes and inform health policy. We created, tested, and calibrated a model of CMV acquisition and transmission in pregnancy using linked mother-infant dyads.
Methods We developed the Linking INfants and Mothers in Cytomegalovirus Simulation (LINCS) dyad-level Monte-Carlo microsimulation model of CMV infection among pregnant people and fetuses throughout pregnancy. We parameterized the model with data from the existing literature, implemented rigorous code testing procedures, and calibrated a key set of parameters to match model output to external data on cCMV prevalence and symptom risk.
Results A fully parameterized model for CMV among pregnant people and fetuses was developed, and the model code was confirmed to perform as specified. The calibration procedure identified parameter sets that generated model output closely matching the target values from the available data on cCMV prevalence and symptom risk.
Conclusions The LINCS model’s ability to simulate the natural history of CMV infection during pregnancy was described and demonstrated, and the model was tested and calibrated to ensure proper functioning. Base case parameters were derived for CMV infection natural history to be used in future decision analyses of CMV testing and treatment strategies.
Competing Interest Statement
Dr. Prabhu reports royalties from UpToDate, is a consultant for BabyList, Inc, and created a webinar on CMV for Medscape. Dr. Kakkar received research support from Altona Diagnostics. Dr. Pesch serves on the Board of Directors of the National CMV Foundation (unpaid), and is a paid consultant for Moderna Tx, WebMD, and 2ndMD. No other competing interests are reported.
Funding Statement
Financial support for this study was provided by the James and Audrey Foster MGH Research Scholars Award. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the MGH Executive Committee on Research. The funding agreement ensured the authors' independence in designing the study, interpreting the data, writing, and publishing the report.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Indicates co-senior authors
Additional supplementary material (Table S2) uploaded.
Data Availability
The model code used to generate the data and results in the present study is available upon reasonable request to the authors.